655
Participants
Start Date
May 15, 2017
Primary Completion Date
February 9, 2021
Study Completion Date
February 9, 2021
Somatostatin
Lyophilisate and solution for IV use (glass ampoule of lyophilisate + 1 ml glass ampoule of solvent) 6 mg per day Continuous intravenous infusion for 6,5 days
Octreotide
Solution for Subcutaneous use 100μg, every 8 hours Subcutaneous injection for 6,5 days
La Pitié Salpêtrière Hospital, Paris
Cochin Hospital, Paris
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER